Literature DB >> 59740

The induction of prostatic hypertrophy in the dog with androstanediol.

P C Walsh, J D Wilson.   

Abstract

The effects of androstanediol and estradiol on prostatic growth were investigated in castrate dogs. Estrogens along resulted in no significant change in prostatic weight, whereas androstanediol produced growth comparable to that in uncastrated controls. Androstanediol plus estradiol resulted in an even more striking increase in prostate growth. Approximately half the animals receiving androstanediol alone and all of those receiving androstanediol plus estradiol fulfill the weight and histological criteria for prostatic hypertrophy in the dog. Since both these steroid hormones are presumed to be normal secretory products of the testis, it is possible that they are involved in the pathogenesis of prostatic hypertrophy in the dog.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 59740      PMCID: PMC436755          DOI: 10.1172/JCI108353

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  13 in total

1.  Parenchymatous hypertrophy of the canine prostate gland.

Authors:  O A BERG
Journal:  Acta Endocrinol (Copenh)       Date:  1958-02

2.  The normal prostate gland of the dog.

Authors:  O A BERG
Journal:  Acta Endocrinol (Copenh)       Date:  1958-02

3.  Studies on the canine prostate gland. I. Factors influencing its size and weight.

Authors:  J D O'SHEA
Journal:  J Comp Pathol       Date:  1962-07       Impact factor: 1.311

4.  Estrogen and castration-induced effects on canine prostatic fine structure and C-19-steroid metabolism.

Authors:  I Leav; R F Morfin; P Ofner; L F Cavazos; E B Leeds
Journal:  Endocrinology       Date:  1971-08       Impact factor: 4.736

5.  The signs and results of treatment of prostatic disease in dogs.

Authors:  R Borthwick; C P Mackenzie
Journal:  Vet Rec       Date:  1971-10       Impact factor: 2.695

Review 6.  Effects and metabolism of hormones in normal and neoplastic prostate tissue.

Authors:  P Ofner
Journal:  Vitam Horm       Date:  1968       Impact factor: 3.421

7.  The effect of androgenic hormones on the reduced nicotinamide adenine dinucleotide phosphate:delta-4-3-ketosteroid 5 alpha-oxidoreductase of rat ventral prostate.

Authors:  R J Moore; J D Wilson
Journal:  Endocrinology       Date:  1973-09       Impact factor: 4.736

8.  Dihydrotestosterone in prostatic hypertrophy. II. The formation and content of dihydrotestosterone in the hypertrophic canine prostate and the effect of dihydrotestosterone on prostate growth in the dog.

Authors:  R E Gloyna; P K Siiteri; J D Wilson
Journal:  J Clin Invest       Date:  1970-09       Impact factor: 14.808

9.  Dihydrotestosterone in prostatic hypertrophy. I. The formation and content of dihydrotestosterone in the hypertrophic prostate of man.

Authors:  P K Siiteri; J D Wilson
Journal:  J Clin Invest       Date:  1970-09       Impact factor: 14.808

10.  Estradiol and testosterone secretion by human, simian, and canine testes, in males with hypogonadism and in male pseudohermaphrodites with the feminizing testes syndrome.

Authors:  R P Kelch; M R Jenner; R Weinstein; S L Kaplan; M M Grumbach
Journal:  J Clin Invest       Date:  1972-04       Impact factor: 14.808

View more
  48 in total

Review 1.  Morphologic and regulatory aspects of prostatic function.

Authors:  G Aumüller
Journal:  Anat Embryol (Berl)       Date:  1989

Review 2.  Estrogens and Male Lower Urinary Tract Dysfunction.

Authors:  Jalissa L Wynder; Tristan M Nicholson; Donald B DeFranco; William A Ricke
Journal:  Curr Urol Rep       Date:  2015-09       Impact factor: 3.092

Review 3.  Fibroblasts are critical determinants in prostatic cancer growth and dissemination.

Authors:  L W Chung
Journal:  Cancer Metastasis Rev       Date:  1991-10       Impact factor: 9.264

Review 4.  Androgens and estrogens in benign prostatic hyperplasia: past, present and future.

Authors:  Tristan M Nicholson; William A Ricke
Journal:  Differentiation       Date:  2011-05-26       Impact factor: 3.880

5.  Regulation of cytoplasmic dihydrotestosterone binding in dog prostate by 17 beta-estradiol.

Authors:  R J Moore; J M Gazak; J D Wilson
Journal:  J Clin Invest       Date:  1979-03       Impact factor: 14.808

6.  Specificity of androgen resistance in Mus caroli kidney.

Authors:  C M Wilson; D F Kimberlin; J E Griffin; J D Wilson
Journal:  Biochem Genet       Date:  1988-12       Impact factor: 1.890

7.  Purification and properties of a 3 alpha-hydroxysteroid dehydrogenase of rat liver cytosol and its inhibition by anti-inflammatory drugs.

Authors:  T M Penning; I Mukharji; S Barrows; P Talalay
Journal:  Biochem J       Date:  1984-09-15       Impact factor: 3.857

8.  Bipotentiality of response to sex hormones by the prostate of castrated or hypophysectomized dogs. Direct effects of estrogen.

Authors:  I Leav; F B Merk; P Ofner; G Goodrich; P W Kwan; B M Stein; M Sar; W E Stumpf
Journal:  Am J Pathol       Date:  1978-10       Impact factor: 4.307

9.  5alpha-androstane-3alpha,17beta-diol selectively activates the canonical PI3K/AKT pathway: a bioinformatics-based evidence for androgen-activated cytoplasmic signaling.

Authors:  Mikhail G Dozmorov; Qing Yang; Adam Matwalli; Robert E Hurst; Daniel J Culkin; Bradley P Kropp; Hsueh-Kung Lin
Journal:  Genomic Med       Date:  2008-02-27

10.  Etiopathogenesis of benign prostatic hypeprlasia.

Authors:  Jie Tang; Jingchun Yang
Journal:  Indian J Urol       Date:  2009-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.